Biblio Discovery — Demo Discovery Service

15 results for "Jane Collier"

Showing 1–15 · 0.53 seconds · RSS

  1. Journal Article

    Barriers to cardiovascular disease secondary prevention care in the West Bank, Palestine – a health professional perspective

    Jane Collier; Hanna Kienzler

    Conflict and Health, Vol. 12 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Non-communicable diseases (NCDs) - including cardiovascular disease (CVD), cancer and diabetes - have become a significant global burden on health. Particularly concerning are CVD rates, causing approximately 18 million deaths worldwide every year. The statistics show that the…

  2. Journal Article

    Intersectionality, equity-mindedness, and access to care

    Naomi W. Nishi; Erin Watley; Mary Jane Collier et al.

    Frontiers in Veterinary Science, Vol. 12 · 2025 · English · DOAJ Scopus

    The factors that contribute to an individual’s and/or community’s access to veterinary care for their animal(s) are manifold. While some (potential) clients must navigate barriers, including transportation options, time off during business hours, physical access, cost of care, and language…

  3. Journal Article

    A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High‐Risk Primary Sclerosing Cholangitis

    Emmanuel A. Selvaraj; Ahmed Ba‐Ssalamah; Sarah Poetter‐Lang et al.

    Hepatology Communications, Vol. 6 No. 4 · 2022 · English · DOAJ Scopus

    Magnetic resonance imaging with magnetic resonance cholangiopancreatography (MRI‐MRCP) in primary sclerosing cholangitis (PSC) is currently based on qualitative assessment and has high interobserver variability. We investigated the utility and performance of quantitative metrics derived from a…

  4. Journal Article Full text

    Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study

    Christina Levick; Jane Phillips-Hughes; Jane Collier et al.

    PLOS ONE, Vol. 14 No. 8 · 2019 · English · PLOS Scopus

    Background and aims: Non-invasive assessment of portal hypertension is an area of unmet need. This proof of concept study aimed to evaluate the diagnostic accuracy of a multi-parametric magnetic resonance technique in the assessment of portal hypertension. Comparison to other non-invasive…

    Also available at: DOAJ

  5. Journal Article

    Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 1; peer review: 2 approved]

    Louise O. Downs; Anna L. McNaughton; Mariateresa de Cesare et al.

    Wellcome Open Research, Vol. 5 · 2020 · English · DOAJ Scopus

    Deep sequencing of the full-length hepatitis B virus (HBV) genome provides the opportunity to determine the extent to which viral diversity, genotype, polymorphisms, insertions and deletions may influence presentation and outcomes of disease. Increasing experience with analysis of HBV genomic data…

  6. Journal Article

    Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 2; peer review: 2 approved]

    Louise O. Downs; Anna L. McNaughton; Mariateresa de Cesare et al.

    Wellcome Open Research, Vol. 5 · 2021 · English · DOAJ Scopus

    Deep sequencing of the full-length hepatitis B virus (HBV) genome provides the opportunity to determine the extent to which viral diversity, genotype, polymorphisms, insertions and deletions may influence presentation and outcomes of disease. Increasing experience with analysis of HBV genomic data…

  7. Journal Article

    Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

    Emily Adland; Gerald Jesuthasan; Louise Downs et al.

    BMC Infectious Diseases, Vol. 18 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate…

  8. Journal Article

    Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis

    Bhavika Parmanand; Michael Watson; Karen J. Boland et al.

    JHEP Reports, Vol. 2 No. 6 · 2020 · English · DOAJ Scopus

    Background & Aims: Iron reduction by venesection has been the cornerstone of treatment for haemochromatosis for decades, and its reported health benefits are many. Repeated phlebotomy can lead to a compensatory increase in intestinal iron absorption, reducing intestinal iron availability. Given…

  9. Journal Article

    Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study

    Tingyan Wang; David A. Smith; Cori Campbell et al.

    BMC Infectious Diseases, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Current clinical guidelines recommend treating chronic hepatitis B virus (HBV) infection in a minority of cases, but there are relatively scarce data on evolution or progression of liver inflammation and fibrosis in cases of chronic HBV (CHB) that do not meet treatment criteria…

  10. Journal Article

    Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection

    Louise O. Downs; David A. Smith; Sheila F. Lumley et al.

    mBio, Vol. 10 No. 3 · 2019 · English · DOAJ Scopus

    ABSTRACT HBsAg and HBeAg have gained traction as biomarkers of control and clearance during chronic hepatitis B virus infection (CHB). Improved understanding of the clearance correlates of these proteins could help inform improvements in patient-stratified care and advance insights into the…

  11. Journal Article Full text

    Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

    Leo Swadling; John Halliday; Christabel Kelly et al.

    Vaccines, Vol. 4 No. 3 · 2016 · English · DOAJ Scopus

    An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of disease associated with chronic HCV infection. A…

  12. Journal Article Full text

    Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus

    Aminata Sy; Leanne McCabe; Emma Hudson et al.

    PLOS ONE, Vol. 18 No. 1 · 2023 · English · PLOS Scopus

    Background: The CC genotype of the IFNL4 gene is known to be associated with increased Hepatitis C (HCV) cure rates with interferon-based therapy and may contribute to cure with direct acting antivirals. The Genedrive® IFNL4 is a CE marked Point of Care (PoC) molecular diagnostic test, designed for…

    Also available at: DOAJ

  13. Journal Article

    Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK [version 2; peer review: 2 approved]

    Eleni Nastouli; Eleanor Barnes; Graham S. Cooke et al.

    Wellcome Open Research, Vol. 7 · 2023 · English · DOAJ Scopus

    Background To determine the impact of the COVID-19 pandemic on the population with chronic Hepatitis B virus (HBV) infection under hospital follow-up in the UK, we quantified the coverage and frequency of measurements of biomarkers used for routine surveillance (alanine transferase [ALT] and HBV…